Dexcom G7 Continuous Glucose Monitor Cleared by the FDA
Dexcom G7® Continuous Glucose Monitor system was cleared by the FDA, giving people with diabetes more options for managing their blood-sugar levels.
Breakthrough T1D Children’s Congress: Creating Advocacy Warriors
The terms “type 1 diabetes” and “ninja warrior” aren’t usually connected. That is, unless you’re Katie Bone, a 16-year old with T1D and fierce competitor on the hit show American Ninja Warrior.
FDA Approves Tzield™—A Watershed Moment for the T1D Community
Breakthrough T1D celebrates the FDA approval of Tzield, the first disease-modifying therapy to delay clinical T1D in people at risk of developing the disease.
What To Know about Medicare and Type 1 Diabetes for 2023
Medicare and type 1 diabetes (T1D)
Breakthrough T1D Children’s Congress: Motivating T1D Youth to Pay it Forward
Breakthrough T1D Children's Congress changed Jasmine Meriedy's perspective on life with T1D. She's using that confidence to pay it forward.
Breakthrough T1D Children’s Congress: Inspiring the Next Generation of Advocates
For Kabir Dewan, being a Breakthrough T1D 2019 Children's Congress Delegate was one of the most fulfilling and meaningful experiences of his life.
Breakthrough T1D Children’s Congress: Shaping Future Policymakers
For Breakthrough T1D 2015 Children's Congress Delegate Berkeley Barnett, being a voice for the T1D community changed the course of her life.
One Important Step Towards Affordable Insulin
Congress passes the Inflation Reduction Act, which contains provisions that will make insulin affordable for some Americans. Much more must be done.
Breakthrough T1D Urges Senate to Support Insulin Affordability Provisions as Part of Inflation Reduction Act of 2022
Breakthrough T1D Urges Senate to Support Insulin Affordability Provisions as Part of Inflation Reduction Act of 2022
California to Manufacture Insulin
California Governor Gavin Newsome announced plans for the state to manufacture and distribute its own insulin.
